CoreValve Inc., a heart valve maker that moved from France to Irvine last year, has raised $33 million in a third round of venture funding.
The company’s move was based in part on the need to raise more money for the development of a heart valve inserted via a catheter rather than open heart surgery.
The latest round brings CoreValve’s total raised to $63 million.
Maverick Capital led the funding. Returning investors Apax Partners, HealthCap and Sofinnova Partners also took part.
CoreValve is looking to get European Union approval for its valve this year, according to the company.
It could seek U.S. approval by 2010 or so.
